The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression

JAMA

Volumn 277, Issue 4, 1997, Pages 333-340

  Hirschfeld, Robert M A ^a,b   Keller, Martin B ^a   Panico, Susan ^a   Arons, Bernard S ^a   Barlow, David ^a   Davidoff, Frank ^a   Endicott, Jean ^a   Froom, Jack ^a   Goldstein, Michael ^a   Gorman, Jack M ^a   Guthrie, Don ^a   Marek, Richard G ^a   Maurer, Theodore A ^a   Meyer, Roger ^a   Phillips, Katharine ^a   Ross, Jerilyn ^a   Schwenk, Thomas L ^a   Sharfstein, Steven S ^a   Thase, Michael E ^a   Wyatt, Richard J ^a  

^a Natl Depress/Manic Depress Assoc   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

CONFERENCE PAPER; DEPRESSION; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL EXPERT; MEDICAL LITERATURE; MEDICAL SOCIETY; MENTAL HEALTH CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 18144432661     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.4.333     Document Type: Conference Paper

References (38)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
2. Keller MB, Harrison W, Fawcett JA, et al. Treatment of chronic depression with sertraline and imipramine: preliminary blinded response rates and high rates of undertreatment in the community. Psychophannacol Bull. 1995;31:205-212.
3. Kocsis JH, Friedman RA, Markowitz JC, et al. Maintenance therapy for chronic depression: a controlled clinical trial of desipramine. Arch Gen Psychiatry. In press.
4. Shelton RC, Davidson J, Yonkers K, et al. The undertreatment of dysthymia. J Clin Psychiatry. In press.
5. Kocsis JH, Frances AJ, Voss C, Mann JJ, Mason BJ, Sweeney J. Imiprarnine treatment for chronic depression. Arch Gen Psychiatry. 1988;45:253-257
6. Kessler RC, McGonagle KA, Zhao, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
7. Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto US Mental and Addictive Disorders Service System: Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry. 1993;50:84-94.
8. Shapiro S, Skinner EA, Kessler LG, et al. Utilization of health and mental health services: three Epidemiological Catchment Area sites. Arch Gen Psychiatry. 1984;41:971-978.
9. Cross-National Collaborative Group. The changing rate of major depression. JAMA. 1992;268:3098-3105.
10. Klerman GL, Weissman MM. Increasing rates of depression. JAMA. 1989;261:2229-2235.
11. Robins LN, Regier DA, eds. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York, NY: Free Press; 1991.
12. Keller MB, Klerman GL, Lavori PW, Fawcett JA, Coryell W, Endieott J. Treatment received by depressed patients. JAMA. 1982;48:1848-1855.
13. Keller MB, Lavori PW, Klerman GL, et al. Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Arch Gen Psychiatry. 1986;43:458-466.
14. Simon GE, vonKorff M. Recognition, management, and outcomes of depression in primary care. Arch Fam Med. 1995;4:99-105.
15. Coyne JC, Fechner-Bates S, Schwenk TL, Prevalence, nature, and comorbidity of depressive disorders in primary care. Gen Hosp Psychiatry. 1994;16:267-276.
16. Katon W, von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care. 1992;30:67-76.
17. Goethe JW, Szarek BL, Cook WL. A comparison of adequately vs inadequately treated depressed inpatients. J Nerv Ment Dis. 1988;176:464-470.
18. Keller MB. Undertreatment of major depression. Psychopharmacol Bull. 1988;24:75-80.
19. Keller MB, Klerman GL, Lavori PW, Coryell W, Endicott J, Taylor J. Long-term outcome of episodes of major depression: clinical and public health significance. JAMA. 1984;252:788-792.
20. Keller MB, Lavori PW, Lewis CE, Klerman GL. Predictors of relapse in major depressive disorder. JAMA. 1983;250:3299-3304.
21. Keller MB, Lavori PW, Rice J, Coryell W, Hirschfeld RMA. The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: a prospective follow-up. Am J Psychiatry. 1986;143:24-28.
22. Finkelstein SN, Berndt ER, Greenberg PE. Economics of Depression: A Summary and Review. Prepared for the National Depressive and Manie-Depressive Association-sponsored Consensus Conference on the Undertreatment of Depression, January 17-18, 1996.
23. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry. 1993;54:405-418.
24. Stoudemire A, Frank R, Hedemark N, Kamlet M, Blazer D. The economic burden of depression. Gen Hosp Psychiatry. 1986;8:387-394.
25. Hall RCW, Wise MG. The clinical and financial burden of mood disorders. Psychosomatics. 1995; 36:S11-S18.
26. Greenberg PE, Kessler RC, Nells TL, Finkelstein SN, Berndt ER. Depression in the workplace: an economic perspective. In: Feighner JP, Boyer WF. Selective Serotonin Re-uptake Inhibitors: Advances in Basic Research and Clinical Practice. 2nd ed. New York, NY: John Wiley & Sons Ltd; 1996.
27. Conti DJ, Burton WN. Economic impact of depression in a workplace. J Occup Environ Med. 1994;36:983-988.
28. Wells KB, Stewart A, Hays RD, et al. The functioning and well being of depressed patients: results from the Medical Outcomes Study. JAMA. 1989;262:914-919.
29. Sturm K, Wells K. How can care for depression become more cost-effective? JAMA. 1995;273:51-58.
30. Mintz J, Mintz LI, Arruda MJ, Hwang SS. Treatment of depression and the functional capacity to work. Arch Gen Psychiatry. 1992;49:761-768.
31. Rupp A. The economic consequences of not treating depression. Br J Psychiatry. 1995;166(suppl): 29-33.
32. National Mental Health Association's Public Campaign, National Public Education Campaign on Clinical Depression (NPECCD). Advertising and media (national and local) April 1993; material distribution April 1993-present; local campaigns, January 1993-present.
33. Endieott J, Blumenthal R. Barriers to seeking treatment for major depression. Presented at the Annual Scientific Meeting of the New York State Office of Mental Health, Albany, NY, December 1996.
34. Jarrett RB, Rush AJ. Short-term psychotherapy of depressive disorders: current status and future directions. Psychiatry. 1994;57:115-132.
35. McFarland BH. Cost effectiveness considerations for managed care systems: treating depression in primary care. Am J Med. 1994;97(suppl 6A): 47S-57S.
36. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
37. Katon W, von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA. 1995;273:1026-1031.
38. Health Plan Employer Data and Information Set. Washington, DC: National Committee for Quality Assurance; July 1996.